Role of BCRP 421C>A and 34G>A polymorphisms on rosuvastatin pharmacokinetics in healthy Chinese males and its molecular mechanism

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-RCH-12002706

Enrollment

Unknown

Registered

2012-11-20

Start date

2012-06-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Case series:Nil

Eligibility

Sex/Gender

Male

Age

18 Years to 26 Years

Inclusion criteria

Inclusion criteria: healthy Chinese males with C421A and G34A

Exclusion criteria

Exclusion criteria: CYP2C9 and OATP 1B1 with SNPs

Design outcomes

Primary

Measure	Time frame
pharmacokinetics indexes;	—

Countries

China

Contacts

Public ContactGuo Wang

wangguo30@yahoo.com.cn+86 18874878082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026